• ICT Ep17: Exploring Enrollment Gaps in Oncology Trials with Selin Kurnaz (Part 2 of 3)

  • 2024/10/09
  • 再生時間： 17 分
  • ポッドキャスト

ICT Ep17: Exploring Enrollment Gaps in Oncology Trials with Selin Kurnaz (Part 2 of 3)

無料で聴く

ポッドキャストの詳細を見る

  • サマリー

  • In this episode of Innovating Clinical Trials, hosts Liam Eves and Ted Trafford continue their discussion with Selin Kurnaz, CEO and founder of Massive Bio, an AI-powered platform that connects cancer patients with clinical trials. The conversation centers around the critical challenges in oncology trial enrollment, from recruitment failures to the operational difficulties encountered in the "Last Mile." We discuss the need for transparency, education, and a rethinking of traditional clinical trial processes. Selin discusses the complexity of site selection, prescreening, and patient identification, highlighting that the current system often overlooks the operational steps that are crucial for successful trial participation.

    続きを読む 一部表示

あらすじ・解説

In this episode of Innovating Clinical Trials, hosts Liam Eves and Ted Trafford continue their discussion with Selin Kurnaz, CEO and founder of Massive Bio, an AI-powered platform that connects cancer patients with clinical trials. The conversation centers around the critical challenges in oncology trial enrollment, from recruitment failures to the operational difficulties encountered in the "Last Mile." We discuss the need for transparency, education, and a rethinking of traditional clinical trial processes. Selin discusses the complexity of site selection, prescreening, and patient identification, highlighting that the current system often overlooks the operational steps that are crucial for successful trial participation.

生物科学
続きを読む 一部表示

ICT Ep17: Exploring Enrollment Gaps in Oncology Trials with Selin Kurnaz (Part 2 of 3)に寄せられたリスナーの声

カスタマーレビュー：以下のタブを選択することで、他のサイトのレビューをご覧になれます。

Audible.co.jp

Amazon.co.jp
レビューはまだありません。